In Brief
This article was originally published in The Tan Sheet
Executive Summary
Sen. Hatch on path to re-election; Senate passes FDA Safety and Innovation Act; DSM petitions FDA for folic acid fortification of masa flour; Nutrition 21 returns under new management; ZO Skin Health defends trademarks; more news In Brief.
You may also be interested in...
InterHealth Responsible For Zychrome Claims By Manufacturers – NAD
NAD recommends InterHealth discontinue superiority claims comparing its Zychrome chromium dinicocysteinate ingredient to Nutrition 21’s chromium picolinate product, Chromax. The decision tracks FTC’s position of holding branded ingredient suppliers responsible for claims made by their customers.
InterHealth Responsible For Zychrome Claims By Manufacturers – NAD
NAD recommends InterHealth discontinue superiority claims comparing its Zychrome chromium dinicocysteinate ingredient to Nutrition 21’s chromium picolinate product, Chromax. The decision tracks FTC’s position of holding branded ingredient suppliers responsible for claims made by their customers.
Harkin Exit Intensifies Industry Need To Bolster Supplement Caucus
One of DSHEA’s chief authors, Tom Harkin will retire from the Senate after 2014, pressuring supplement industry leaders to identify the next generation of congressional supporters. CRN’s Steve Mister says it will not be possible to replace the duo of Harkin and Orrin Hatch, who is retiring after 2018.